Cupat, Erlinda G.
HRN: 21-28-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2022
AZITHROMYCIN 500MG TABLET (TAB)
04/27/2022
05/01/2022
ORAL
500mg
Q24
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes